Source: International Congress 2015 – Inhaled drugs: within and beyond the lungs



Rating:

Share or cite this content

Citations should be made in the following way:
Bruce K Rubin (Winston-Salem, United States of America). Delivering drugs to the body through the lungs. International Congress 2015 – Inhaled drugs: within and beyond the lungs

Member's Comments

No comment yet.

Related content which might interest you: Delivering inhaled drugs to the small airways - Does it matter? Source: International Congress 2015 – Inhaled drugs: within and beyond the lungs Year: 2015 Targeting of drugs to the lung Source: Annual Congress 2003 - COPD vs AAT deficiency - similarities and differences Year: 2003 Impact of body weight on lung volumes in patients with pulmonary diseases Source: Annual Congress 2010 - Lung morbidity on exposure to various agents Year: 2010 How to protect severely injured lungs: non-pharmacological interventions Source: Annual Congress 2013 –Minimising ventilator-induced lung injury today and tomorrow Year: 2013 Topically applied budesonide and formoterol in combination inhibit rat lung oedema in a synergistic way but counteract the slight systemic effects of each drug alone on body weight gain Source: Eur Respir J 2002; 20: Suppl. 38, 387s Year: 2002 How to use new immunosuppressive drugs in lung transplantation Source: Annual Congress 2006 - MP5 – How to use new immunosuppressive drugs in lung transplantation Year: 2006 Corticosteroids exaggerate the effect of cigarette smoke exposure on body weight and skeletal muscle mass in mice Source: Eur Respir J 2005; 26: Suppl. 49, 717s Year: 2005 Distribution of technetium-99m-labelled QVARTM delivered using an AutohalerTM device in children Source: Eur Respir J 2003; 21: 1007-1011 Year: 2003 Inhaled solid lipid nanoparticles as a new tool for drug delivery in the lung Source: Annual Congress 2009 - New drugs for airways disease Year: 2009 Evaluation of drug induced liver injury due to anti tuberculous drugs in directly observed daily therapy Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe Year: 2016 Precise dosing of five drugs commonly used by patients with cystic fibrosis using an adaptive aerosol delivery system Source: Annual Congress 2008 - Cystic fibrosis: new mechanisms, monitoring and treatment tools Year: 2008 Interferon-? liposome: a new system to improve drug delivery in the treatment of lung cancer Source: ERJ Open Res, 7 (3) 00555-2020; 10.1183/23120541.00555-2020 Year: 2021 Acceptability of capnography-assisted respiratory therapy: a new mind–body intervention for COPD Source: ERJ Open Res, 7 (4) 00256-2021; 10.1183/23120541.00256-2021 Year: 2021 Intrapulmonary drug administration in neonatal and paediatric critical care: a comprehensive review Source: Eur Respir J 2011; 37: 678-689 Year: 2011 Integrating high dose inhaled corticosteroids into oral corticosteroids stewardship Source: Eur Respir J, 55 (1) 1902193; 10.1183/13993003.02193-2019 Year: 2020 Pulmonary surfactant as drug delivery system to target lung epithelium: new approach for the treatment of epithelial injury after bleomycin challenge Source: International Congress 2018 – Regenerative and anti-fibrotic approaches Year: 2018 Rational use of anti-tuberculosis drugs in the EU: better patient care and less drug resistance Source: Eur Respir J 2012; 39: 802-804 Year: 2012 Medical nanoparticles for next generation drug delivery to the lungs Source: Eur Respir J 2014; 44: 765-774 Year: 2014